Rajeev Juneja, managing director of Mankind Pharma, discusses the company's plans to collaborate with celebrities like ...
Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...
Mankind Pharma on Thursday said its consolidated net profit declined 16.5 per cent to Rs 384 crore in the third quarter ended December 31, 2024. The company had reported a net profit of Rs 460 crore ...
India's shares fell on Tuesday due to uncertainty over Donald Trump's plans for India after the U.S. President announced trade tariffs on neighbouring countries within hours of taking office.
New Delhi: Mankind Pharma has said in a BSE filing that the tax authority ... "GST Authority has passed the Order, pursuant to GST audit for the FY 2017-18 to FY 2021-22 on the contention that there ...
Mankind Pharma Ltd on Wednesday said it has been imposed a GST related penalty of over Rs 2 crore by tax authority in Kolkata over alleged mismatch in figures for the period of FY18 to FY22.
On Wednesday, skincare brand Foxtale announced that it has raised $30 million (approximately Rs250 crore) in its Series C funding round. This round saw participation from Japanese cosmetics and ...
Mankind Pharma Ltd. on Wednesday said it has been imposed a GST related penalty of over Rs 2 crore by tax authority in Kolkata over alleged mismatch in figures for the period of fiscal 2018 to 2022.
The company has received an order on January 14, 2025 from Office of the Commissioner of Kolkata South CGST & CX -- issued by Additional Commissioner, Mankind Pharma said in a regulatory filing. "The ...
Mankind Pharma was penalized over Rs 2 crore by the GST authority in Kolkata for alleged mismatch in figures during FY18 to FY22. The company plans to appeal the order. New Delhi, Jan 15 (PTI) Mankind ...
Mankind Pharma Ltd announced on Wednesday that it has been slapped with a GST penalty of Rs 2.27 crore by the Kolkata tax authority. The penalty stems from alleged discrepancies in reported figures ...
The company has received an order on January 14, 2025 from Office of the Commissioner of Kolkata South CGST & CX -- issued by Additional Commissioner, Mankind Pharma said in a regulatory filing.